The Netter Collection of Medical Illustrations: Integumentary System, Volume 4 - Elsevier E-Book on VitalSource (Retail Access Card), 3rd Edition

SECTION 1 ANATOMY, EMBRYOLOGY, AND PHYSIOLOGY
1.1 Embryology of the Skin
1.2 Normal Skin Anatomy
1.3 Normal Skin Histology
1.4 Skin Physiology: The Process of Keratinization
1.5 Normal Skin Flora
1.6 Vitamin D Metabolism
1.7 Photobiology
1.8 Wound Healing
1.9 Morphology: Lichenification, Plaques, and Fissures
1.10 Morphology: Macules, Patches, and Vesiculopustules

SECTION 2 BENIGN GROWTHS
2.1 Acrochordon
2.2 Becker’s Nevus (Smooth Muscle Hamartoma)
2.3 Dermatofibroma (Sclerosing Hemangioma)
2.4 Eccrine Poroma
2.5 Eccrine Spiradenoma
2.6 Eccrine Syringoma
2.7 Ephelides and Lentigines
2.8 Ephelides and Lentigines (Continued)
2.9 Epidermal Inclusion Cyst
2.10 Epidermal Nevus
2.11 Fibrofolliculoma
2.12 Fibrous Papule
2.13 Ganglion Cyst
2.14 Glomus Tumor and Glomangioma
2.15 Hidradenoma Papilliferum
2.16 Hidrocystoma
2.17 Keloid and Hypertrophic Scar
2.18 Leiomyoma
2.19 Lichenoid Keratosis
2.20 Lipoma
2.21 Median Raphe Cyst
2.22 Melanocytic Nevi: Blue Nevi
2.23 Melanocytic Nevi: Common Acquired Nevi and Giant Congenital Melanocytic Nevi
2.24 Melanocytic Nevi: Congenital Nevi
2.25 Milia
2.26 Neurofibroma
2.27 Nevus Lipomatosus Superficialis
2.28 Nevus of Ota and Nevus of Ito
2.29 Nevus Sebaceous
2.30 Osteoma Cutis
2.31 Palisaded Encapsulated Neuroma
2.32 Pilar Cyst (Trichilemmal Cyst)
2.33 Porokeratosis
2.34 Pyogenic Granuloma
2.35 Reticulohistiocytoma
2.36 Seborrheic Keratosis
2.37 Spitz Nevus

SECTION 3 MALIGNANT GROWTHS
3.1 Adnexal Carcinoma
3.2 Angiosarcoma
3.3 Basal Cell Carcinoma: Basic Facial Anatomy
3.4 Basal Cell Carcinoma: Clinical and Histologic Evaluation
3.5 Bowen Disease
3.6 Bowenoid Papulosis
3.7 Cutaneous Metastases
3.8 Dermatofibrosarcoma Protuberans
3.9 Mammary and Extramammary Paget Disease
3.10 Kaposi Sarcoma
3.11 Keratoacanthoma
3.12 Melanoma: Mucocutaneous Malignant Melanoma
3.13 Melanoma: Metastatic Melanoma
3.14 Melanoma: Therapeutics
3.15 Merkel Cell Carcinoma
3.16 Mycosis Fungoides: Clinical Subtypes of Cutaneous T-Cell Lymphoma
3.17 Mycosis Fungoides: Histologic Analysis of Cutaneous T-Cell Lymphoma
3.18 Sebaceous Carcinoma
3.19 Squamous Cell Carcinoma: Genital Squamous Cell Carcinoma
3.20 Squamous Cell Carcinoma: Clinical and Histologic Evaluation

SECTION 4 RASHES
4.1 Acanthosis Nigricans
4.2 Acne: Vulgaris
4.3 Acne: Variants
4.4 Acne: Keloidalis Nuchae
4.5 Acute Febrile Neutrophilic Dermatosis (Sweet Syndrome)
4.6 Allergic Contact Dermatitis: Morphology
4.7 Allergic Contact Dermatitis: Patch Testing and Type IV Hypersensitivity
4.8 Atopic Dermatitis: Infants and Children
4.9 Atopic Dermatitis: Adolescents and Adults
4.10 Autoinflammatory Syndromes: Pathophysiology
4.11 Autoinflammatory Syndromes: Clinical Manifestations
4.12 Bug Bites: Brown Recluse Spiders and Scabies Mites
4.13 Bug Bites: Arthropods and Diseases They Carry
4.14 Calciphylaxis
4.15 Cutaneous Lupus: Band Test
4.16 Cutaneous Lupus: Systemic Manifestations of Systemic Lupus Erythematosus
4.17 Cutaneous Lupus: Manifestations
4.18 Cutis Laxa
4.19 Dermatomyositis: Manifestations
4.20 Dermatomyositis: Cutaneous and Laboratory Findings
4.21 Disseminated Intravascular Coagulation
4.22 Elastosis Perforans Serpiginosa
4.23 Eruptive Xanthomas: Congenital Hyperlipoproteinemia
4.24 Eruptive Xanthomas: Acquired Hyperlipoproteinemia
4.25 Erythema Ab Igne
4.26 Erythema Annulare Centrifugum
4.27 Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis
4.28 Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis (Continued)
4.29 Erythema Nodosum
4.30 Fabry Disease
4.31 Fixed Drug Eruption
4.32 Gout: Gouty Arthritis
4.33 Gout: Tophaceous Gout
4.34 Graft-Versus-Host Disease
4.35 Granuloma Annulare
4.36 Graves Disease and Pretibial Myxedema
4.37 Hidradenitis Suppurativa (Acne Inversa)
4.38 Infantile Hemangiomas
4.39 Irritant Contact Dermatitis
4.40 Keratosis Pilaris
4.41 Langerhans Cell Histiocytosis: Presentation in Childhood
4.42 Langerhans Cell Histiocytosis: Eosinophilic Granuloma
4.43 Leukocytoclastic Vasculitis
4.44 Lichen Planus
4.45 Lichen Simplex Chronicus
4.46 Lower Extremity Vascular Insufficiency
4.47 Mast Cell Disease
4.48 Mast Cell Disease: Degranulation Blockers
4.49 Morphea
4.50 Myxedema
4.51 Necrobiosis Lipoidica
4.52 Necrobiotic Xanthogranuloma
4.53 Neutrophilic Eccrine Hidradenitis
4.54 Ochronosis: Metabolic Pathway and Cutaneous Findings
4.55 Ochronosis: Systemic Findings
4.56 Oral Manifestations in Blood Dyscrasias
4.57 Phytophotodermatitis
4.58 Pigmented Purpura
4.59 Pityriasis Rosea
4.60 Pityriasis Rubra Pilaris
4.61 Polyarteritis Nodosa
4.62 Pruritic Urticarial Papules and Plaques of Pregnancy
4.63 Pseudoxanthoma Elasticum
4.64 Psoriasis: Histopathologic Features and Typical Distribution
4.65 Psoriasis: Inverse Psoriasis and Psoriasis in the Genital Area
4.66 Psoriasis: Psoriatic Arthritis
4.67 Radiation Dermatitis
4.68 Reactive Arthritis (Reiter Syndrome)
4.69 Rosacea
4.70 Sarcoid: Cutaneous Manifestations
4.71 Sarcoid: Systemic Manifestations
4.72 Scleroderma (Systemic Sclerosis)
4.73 Seborrheic Dermatitis
4.74 Skin Manifestations of Inflammatory Bowel Disease: Mucocutaneous Manifestations
4.75 Skin Manifestations of Inflammatory Bowel Disease: Cutaneous Manifestations
4.76 Stasis Dermatitis
4.77 Urticaria
4.78 Vitiligo

SECTION 5 AUTOIMMUNE BLISTERING DISEASES
5.1 Basement Membrane Zone, Hemidesmosome, and Desmosome
5.2 Basement Membrane Zone, Hemidesmosome, and Desmosome (Continued)
5.3 Bullous Pemphigoid
5.4 Mucous Membrane Pemphigoid
5.5 Dermatitis Herpetiformis
5.6 Epidermolysis Bullosa Acquisita
5.7 Linear Immunoglobulin A Bullous Dermatosis
5.8 Paraneoplastic Pemphigus
5.9 Pemphigus Foliaceus
5.10 Pemphigus Vulgaris
SECTION 6 INFECTIOUS DISEASES
6.1 Actinomycosis
6.2 Blastomycosis
6.3 Chancroid
6.4 Coccidioidomycosis
6.5 COVID-19
6.6 Cryptococcosis
6.7 Cutaneous Larva Migrans
6.8 Dermatophytoses: Tinea Faciei and Tinea Corporis
6.9 Dermatophytoses: Tinea Cruris and Tinea Capitis
6.10 Dermatophytoses: Tinea Pedis and Tinea Unguium
6.11 Herpes Simplex Virus: Lesions
6.12 Herpes Simplex Virus: Lesions (Continued)
6.13 Herpes Simplex Virus: Encephalitis
6.14 Histoplasmosis
6.15 Leprosy (Hansen Disease)
6.16 Lice: Clinical Manifestations
6.17 Lice: Clinical Findings and Management
6.18 Lyme Disease
6.19 Lymphogranuloma Venereum
6.20 Meningococcemia: Acute Adrenal Insufficiency (Waterhouse-Friderichsen Syndrome)
6.21 Meningococcemia: Bacterial Meningitis
6.22 Molluscum Contagiosum
6.23 Paracoccidioidomycosis
6.24 Scabies
6.25 Sporotrichosis
6.26 Staphylococcus aureus Skin Infections: Types of Skin Infections
6.27 Staphylococcus aureus Skin Infections: Toxic Shock Syndrome
6.28 Syphilis: Genitalia
6.29 Syphilis: Oral Cavity
6.30 Syphilis: Pregnancy
6.31 Varicella
6.32 Herpes Zoster (Shingles): Clinical Presentation
6.33 Herpes Zoster (Shingles): Varicella Zoster With Keratitis
6.34 Verrucae (Warts): Human Papillomavirus (HPV) Infection
6.35 Verrucae (Warts): Condylomata Acuminata (Genital Warts)

SECTION 7 HAIR AND NAIL DISEASES
7.1 Normal Structure and Function of the Hair Follicle Apparatus
7.2 Normal Structure and Function of the Nail Unit
7.3 Alopecia Areata
7.4 Androgenic Alopecia
7.5 Common Nail Disorders: Fingernail Disorders
7.6 Common Nail Disorders: Toenail Disorders
7.7 Common Nail Disorders (Continued)
7.8 Hair Shaft Abnormalities
7.9 Telogen Effluvium and Anagen Effluvium
7.10 Trichotillomania

SECTION 8 NUTRITIONAL AND METABOLIC DISEASES
8.1 Beriberi: Sources and Metabolism of Thiamine (Vitamin B1)
8.2 Beriberi: Clinical Manifestations of Dry and Wet Beriberi
8.3 Hemochromatosis
8.4 Metabolic Diseases: Niemann-Pick Disease, von Gierke Disease, and Galactosemia
8.5 Pellagra: Main Sources, Causes, and Skin Findings
8.6 Pellagra: Mucosal and Central Nervous System Manifestations
8.7 Phenylketonuria: Normal and Abnormal Metabolism
8.8 Phenylketonuria: Clinical Manifestations and Hereditary Patterns
8.9 Porphyria Cutanea Tarda
8.10 Scurvy: Dietary Sources of Vitamin C and Classic Cutaneous Manifestations
8.11 Scurvy: Bony and Skin Abnormalities
8.12 Vitamin A Deficiency
8.13 Vitamin K Deficiency and Vitamin K Antagonists: Potential Clinical Consequences of Warfarin Use
8.14 Vitamin K Deficiency and Vitamin K Antagonists: Anticoagulation Effects on the Clotting Cascade
8.15 Wilson Disease

SECTION 9 GENODERMATOSES AND SYNDROMES
9.1 Addison Disease
9.2 Amyloidosis
9.3 Basal Cell Nevus Syndrome
9.4 Carney Complex
9.5 Cushing Syndrome and Cushing Disease
9.6 Cushing Syndrome: Pathophysiology
9.7 Down Syndrome
9.8 Ehlers-Danlos Syndrome
9.9 Marfan Syndrome
9.10 Muir-Torre Syndrome
9.11 Neurofibromatosis: Cutaneous Manifestations
9.12 Neurofibromatosis: Cutaneous and Skeletal Manifestations
9.13 Tuberous Sclerosis

Bryan E. Anderson, MD, Professor and Medical Director, Dermatology, Penn State Cancer Institute, The Pennsylvania State University, Hershey, Pennsylvania, USA